BCLI: Brainstorm Cell Therapeutics Inc. Stock

by  •  • Comments Off on BCLI: Brainstorm Cell Therapeutics Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 9.07
Enterprise Value ($M) 8.90
Book Value ($M) -6.06
Book Value / Share -1.06
Price / Book -1.50
NCAV ($M) -7.72
NCAV / Share -1.35
Price / NCAV -1.17

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -3.38
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.05
Current Ratio 0.05

Balance Sheet (mrq) ($M)
Current Assets 0.36
Assets 2.02
Liabilities 8.08
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Armistice Capital, Llc 4.99 -96.29
11-13 13G Ruck Matthew J 5.18
2024-02-12 13G/A Ness Kevin Dean 6.25 -16.39

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ⌧ ANNUAL REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2023 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-07 6,253 21,770 28.72
2025-03-06 8,960 13,671 65.54
2025-03-05 2,983 11,476 25.99
2025-03-04 3,874 10,231 37.87

(click for more detail)

Similar Companies
AWH – Aspira Women's Health Inc. AYTU – Aytu BioPharma, Inc.
BCDA – BioCardia, Inc. BCTX – BriaCell Therapeutics Corp.
BFRG – Bullfrog AI Holdings, Inc.


Financial data and stock pages provided by
Fintel.io